Q4 2023 PDS Biotechnology Corp Earnings Call Transcript
Good morning, and welcome to PDS Biotech's call to discuss the company's year-end 2023 financial results and clinical strategy update conference call. (Operator Instructions) I would now like to turn the conference over to Tom Johnson with LifeSci Advisors.
Please go ahead, sir.
Thank you, operator, and good morning, everyone, and welcome to PDS Biotech's 2023 year-end results and Clinical strategy update call. Today, we will discuss financial results for the year ended December 31, 2023, and provide a business and clinical programs update this morning, the company issued a press release with these results for GE found under the Investor Relations section of the PDS Biotech website.
I'm joined on the call today by the following members of the company's management team, Dr. Frank Bedu-Addo, Chief Executive Officer; Lars Boesgaard, Chief Financial Officer; and Dr. Kirk Shepard, Chief Medical Officer. Dr. Bedu-Addo will begin with a corporate and clinical programs update.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |